Skip to main content
eScholarship
Open Access Publications from the University of California

Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma

  • Author(s): Wang, Y
  • Tong, C
  • Wang, Z
  • Wang, Z
  • Mauger, D
  • Tantisira, KG
  • Israel, E
  • Szefler, SJ
  • Chinchilli, VM
  • Boushey, HA
  • Lazarus, SC
  • Lemanske, RF
  • Wu, R
  • et al.
Abstract

© 2015 Macmillan Publishers Limited Asthma is a chronic lung disease that has a high prevalence. The therapeutic intervention of this disease can be made more effective if genetic variability in patients’ response to medications is implemented. However, a clear picture of the genetic architecture of asthma intervention response remains elusive. We conducted a genome-wide association study (GWAS) to identify drug response-associated genes for asthma, in which 909 622 SNPs were genotyped for 120 randomized participants who inhaled multiple doses of glucocorticoids. By integrating pharmacodynamic properties of drug reactions, we implemented a mechanistic model to analyze the GWAS data, enhancing the scope of inference about the genetic architecture of asthma intervention. Our pharmacodynamic model observed associations of genome-wide significance between dose-dependent response to inhaled glucocorticoids (measured as %FEV1) and five loci (P=5.315 × 10-7 to 3.924 × 10-9), many of which map to metabolic genes related to lung function and asthma risk. All significant SNPs detected indicate a recessive effect, at which the homozygotes for the mutant alleles drive variability in %FEV1. Significant associations were well replicated in three additional independent GWAS studies. Pooled together over these three trials, two SNPs, chr6 rs6924808 and chr11 rs1353649, display an increased significance level (P=6.661 × 10-16 and 5.670 × 10-11). Our study reveals a general picture of pharmacogenomic control for asthma intervention. The results obtained help to tailor an optimal dose for individual patients to treat asthma based on their genetic makeup.The Pharmacogenomics Journal advance online publication, 20 January 2015; doi:10.1038/tpj.2014.83.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View